Pacira Pharma (PCRX) Tops Q3 EPS by 7c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira Pharma (PCRX) Tops Q3 EPS by 7c, Revenues Beat

Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update

October 29, 2020 8:01 AM EDT

-- EXPAREL average daily sales at 110% of the prior year for the third quarter--

-- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported financial results for the third quarter of 2020.

Throughout the third quarter, we continued to make meaningful progress in growing EXPAREL sales despite lingering challenges in the elective surgery market due to the COVID-19 pandemic. The ongoing transition from... More